Incidence, timing, and management of infections in patients receiving teclistamab for the treatment of relapsed/refractory multiple myeloma in the MajesTEC‐1 study
N
Shared by NobleBlocks on Nov 14, 2023 • 12:00 AM UTC
Authors:
A. Nooka
,
Cesar Rodriguez
,
M. Mateos
Research Assistant
AI chat, annotations, notes & similar papers
Finding related papers...
Discussions
(0)
No comments yet
Be the first to share your thoughts!
Incidence, timing, and management of infections in patients receiving teclistamab for the treatment of relapsed/refractory multiple myeloma in the MajesTEC‐1 study | NobleBlocks
